Outset Medical Price to Sales Ratio 2019-2023 | OM

Historical PS ratio values for Outset Medical (OM) over the last 10 years. The current P/S ratio for Outset Medical as of May 03, 2024 is . For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Outset Medical P/S Ratio Historical Data
Date Stock Price TTM Sales per Share Price to Sales Ratio
2024-05-03 3.14 1.19
2023-12-31 5.41 $2.65 2.04
2023-09-30 10.88 $2.70 4.04
2023-06-30 21.87 $2.66 8.21
2023-03-31 18.40 $2.45 7.51
2022-12-31 25.82 $2.41 10.72
2022-09-30 15.93 $2.36 6.75
2022-06-30 14.86 $2.35 6.33
2022-03-31 45.40 $2.38 19.09
2021-12-31 46.09 $2.27 20.30
2021-09-30 49.44 $2.71 18.26
2021-06-30 49.98 $3.26 15.33
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.155B $0.130B
Outset Medical Inc. is a medical technology company. Its Tablo(R) Hemodialysis System represents technological advancement enabling novel, transformational dialysis care in acute and home settings. Outset Medical Inc. is based in CA, United States.
Stock Name Country Market Cap PE Ratio
GE HealthCare Technologies (GEHC) United States $35.527B 19.51
Inspire Medical Systems (INSP) United States $7.610B 0.00
IRhythm Technologies (IRTC) United States $3.451B 0.00
Axonics (AXNX) United States $3.424B 0.00
10x Genomics (TXG) United States $3.133B 0.00
Azenta (AZTA) United States $2.932B 238.96
Olink Holding AB (publ) (OLK) Sweden $2.862B 0.00
Enovis (ENOV) United States $2.859B 21.19
Hims & Hers Health (HIMS) United States $2.622B 0.00
Privia Health (PRVA) United States $2.184B 96.89
Schrodinger (SDGR) United States $1.677B 0.00
Omnicell (OMCL) United States $1.345B 46.49
Phreesia (PHR) United States $1.255B 0.00
Definitive Healthcare (DH) United States $0.823B 0.00
Standard BioTools (LAB) United States $0.734B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.701B 0.00
Fulgent Genetics (FLGT) United States $0.635B 0.00
Talkspace (TALK) United States $0.531B 0.00
Health Catalyst (HCAT) United States $0.386B 0.00
Pulmonx (LUNG) United States $0.361B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.331B 0.00
Clover Health Investments (CLOV) United States $0.319B 0.00
Butterfly Network (BFLY) United States $0.192B 0.00
P3 Health Partners (PIII) United States $0.189B 0.00
American Well (AMWL) United States $0.151B 0.00
Augmedix (AUGX) United States $0.130B 0.00
MSP Recovery (LIFW) United States $0.129B 0.00
TruBridge (TBRG) United States $0.125B 5.32
111 (YI) China $0.094B 0.00
Future Health ESG (FHLT) United States $0.071B 0.00
SHL Telemedicine (SHLT) Israel $0.068B 0.00
NantHealth (NHIQ) United States $0.058B 0.00
HeartBeam (BEAT) United States $0.058B 0.00
Zepp Health (ZEPP) China $0.056B 0.00
Movano (MOVE) United States $0.050B 0.00
EUDA Health Holdings (EUDA) Singapore $0.046B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.033B 0.00
Akili (AKLI) United States $0.032B 0.00
Bullfrog AI Holdings (BFRG) United States $0.024B 0.00
Cue Health (HLTH) United States $0.022B 0.00
Streamline Health Solutions (STRM) United States $0.019B 0.00
CareCloud (CCLD) United States $0.018B 0.00
ETAO (ETAO) United States $0.015B 0.00
Strata Skin Sciences (SSKN) United States $0.014B 0.00
Biotricity (BTCY) United States $0.012B 0.00
Transgenomic (PRPO) United States $0.009B 0.00
Syra Health (SYRA) United States $0.007B 0.00
Predictive Oncology (POAI) United States $0.007B 0.00
HeartSciences (HSCS) United States $0.006B 0.00
Healthcare Triangle (HCTI) United States $0.006B 0.00
Zhongchao (ZCMD) China $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Centogene (CNTG) Germany $0.000B 0.00
MDxHealth SA (MDXH) Belgium $0.000B 0.00
Nyxoah SA (NYXH) Belgium $0.000B 0.00